Get started
Author

Maria Teresa Ferrò

Observed names: M T Ferro, M. Ferro, M. T. FERRÒ, M. T. Ferro, M. T. Ferro’, M. T. Ferrò, M.T Ferro, M.T. FERRO, M.T. Ferro, M.T. Ferrò, M.Teresa Ferro, Maria Pia Sormani, Maria T. Ferro, Maria T. Ferrò, Maria Teresa Ferro, Maria Teresa Ferrò, Maria Teresa Ferro’, Maria Teresa Ferrò, María Teresa Ferro
Observed institutions: University of Bergamo, Hospital Clínico San Carlos, Hospital Universitari i Politècnic La Fe, Azienda Ospedaliera Ospedale Maggiore, Ospedale Policlinico San Martino, Hospital Universitario Ramón y Cajal, Istituti Ospitalieri di Cremona, Aziende Socio Sanitarie Territoriale di Crema, University of Turin, University of Genoa
ORCID: 0000-0003-1888-3510
Observed ORCID: 0000-0003-1888-3510
OpenAlex ID: A5109353478
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies
2021 · Maria Pia Sormani, Matilde Inglese, et al. · EBioMedicine · 226
PDF
Mutations in DNA2 Link Progressive Myopathy to Mitochondrial DNA Instability
2013 · Dario Ronchi, Alessio Di Fonzo, et al. · The American Journal of Human Genetics · 137
PDF
Video-assisted thoracoscopic extended thymectomy and extended transsternal thymectomy (T-3b) in non-thymomatous myasthenia gravis patients: remission after 6 years of follow-up
2003 · Renato Mantegazza, Fulvio Baggi, et al. · Journal of the Neurological Sciences · 123
Clinical correlations of the 3q21;q26 cytogenetic anomaly. A leukemic or myelodysplastic syndrome with preserved or increased platelet production and lack of response to cytotoxic drug therapy
1985 · Tomas Pintado, Maria Teresa Ferro, et al. · Cancer · 103
PDF
Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy
2009 · J. Cervera, P. Montesinos, et al. · Haematologica · 89
PDF
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy
2022 · Maria Pia Sormani, Irene Schiavetti, et al. · EBioMedicine · 84
PDF
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis
2015 · Pietro Iaffaldano, Giuseppe Lucisano, et al. · Brain · 84
PDF
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context
2021 · Maria Pia Sormani, Irene Schiavetti, et al. · Neurology Neuroimmunology & Neuroinflammation · 76
PDF
Impact of natural menopause on multiple sclerosis: a multicentre study
2019 · Damiano Baroncini, Pietro Osvaldo Annovazzi, et al. · Journal of Neurology Neurosurgery & Psychiatry · 72
Risk of Persistent Disability in Patients With Pediatric-Onset Multiple Sclerosis
2021 · Damiano Baroncini, Marta Simone, et al. · JAMA Neurology · 63
PDF
Multiple Sclerosis Progression and Relapse Activity in Children
2023 · Pietro Iaffaldano, Emilio Portaccio, et al. · JAMA Neurology · 55
Quantitative Detection of Epstein-Barr Virus DNA in Cerebrospinal Fluid and Blood Samples of Patients with Relapsing-Remitting Multiple Sclerosis
2014 · Clementina E. Cocuzza, Fabrizio Piazza, et al. · PLoS ONE · 53
PDF
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies
2022 · Irene Schiavetti, Cinzia Cordioli, et al. · Multiple Sclerosis Journal · 48
PDF
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study
2021 · Maria Pia Sormani, Irene Schiavetti, et al. · Multiple Sclerosis Journal · 47
Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosis
2020 · Clara Grazia Chisari, Luigi Maria Grimaldi, et al. · Journal of Neurology Neurosurgery & Psychiatry · 43
Delineation of a duplication map of chromosome 3q: A new case confirms the exclusion of 3q25-q26.2 from the duplication 3q syndrome critical region
1997 · P. Rizzu, B. R. Haddad, et al. · American Journal of Medical Genetics · 35
Ph-positive chronic myeloid leukemia with t(8;21)(q22;q22) in blastic crisis
1992 · M.T. Ferro, J.L. Steegman, et al. · Cancer Genetics and Cytogenetics · 35
Interferon alpha for chronic myeloid leukemia relapsing after allogeneic bone marrow transplantation
1999 · J L Steegmann, L F Casado, et al. · Bone Marrow Transplantation · 29
Video‐assisted Thoracoscopic Extended Thymectomy (VATET) in Myasthenia Gravis Two‐Year Follow‐up in 101 Patients and Comparison with the Transsternal Approach
1998 · R. MANTEGAZZA, P. CONFALONIERI, et al. · Annals of the New York Academy of Sciences · 27
A case of multiple sclerosis with atypical onset associated with autoimmune hepatitis and silent coeliac disease
2008 · Maria Teresa Ferrò, Diego Franciotta, et al. · Neurological Sciences · 24
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis
2020 · Emanuele D’Amico, Aurora Zanghì, et al. · Journal of Neurology · 22
PDF
High resolution chromosome analysis of constitutional and acquired t(15;17) maps c-erbA to Subband 17q11.2
1986 · F. Mitelman, G. Manolov, et al. · Cancer Genetics and Cytogenetics · 19
PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study
2021 · Clara G. Chisari, Giancarlo Comi, et al. · Journal of Neurology · 17
Interstitial deletion in the long arms of chromosome 1: 46,XY,del(1)(pter leads to q22::q25 leads to qter).
1980 · C E de Pablo, J M García Sagredo, et al. · Journal of Medical Genetics · 17
PDF
Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive Multiple Sclerosis
2022 · Emilio Portaccio, Mattia Fonderico, et al. · JAMA Neurology · 16
Works count: 96
Citation count: 2,440
H-index: 23
I10-index: 44
Year
Topic
Type